|
Market Cap (5-Jul) $72,989,640 (564th) |
Close (30-Jun) $0.180 |
Volume (30-Jun) 3,225,766 |
Shortsold (19-Jun) 12,988,365 (0.64%) (278th) |
|
52w High $0.071 |
52w Low $0.026 |
P/E - |
EPS -0.01 |
IPD released this announcement to the ASX on 26 July 2022, 8:16. The announcement is marked as price sensitive, and is 3 page(s) in length and 133.66kb in size.
You can view all announcements from IPD and see how they appear on a price chart on the announcements page.
At the date of this announcement, IPD was 0.182% short sold according to ASIC data. It was ranked the 432nd most shorted stock on the ASX. It is now ranked as the 278th most shorted stock on the ASX with 0.641% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IPD | |
|---|---|
| Revised Security Trading Policy | 30 June 2023, 8:18 |
| ImpediMed Achieves Critical Mass in First Key Target State | 29 June 2023, 9:32 |
| ImpediMed Updates Board for Growth in Oncology | 28 June 2023, 8:22 |
| ImpediMed CEO Announces Departure | 26 July 2022, 8:16 |
| Quarterly Results and Investor Conference Call Notification | 21 July 2022, 8:17 |
| New Heart Failure Data to be Presented at HFSA Meeting | 15 July 2022, 8:20 |
| Lymphoedema Risk Factors Paper Published | 11 July 2022, 8:25 |
You must be logged in to post a reply.
ImpediMed 